These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11179281)

  • 1. Endothelial function and nitric oxide: clinical relevance.
    Vallance P; Chan N
    Heart; 2001 Mar; 85(3):342-50. PubMed ID: 11179281
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo.
    Vallance P
    Cardiovasc Res; 2000 Jan; 45(1):143-7. PubMed ID: 10728327
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function.
    Blantz RC
    Blood Purif; 1994; 12(1):30-5. PubMed ID: 7527221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans.
    Pietropaoli AP; Perkins PT; Perillo IB; Hyde RW
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2113-4. PubMed ID: 10852797
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of extraluminally induced vasoconstrictions by endothelium-derived nitric oxide in the canine basilar artery.
    Minato H; Hashizume M; Masuda Y; Hosoki K
    Arzneimittelforschung; 1995 Jun; 45(6):675-8. PubMed ID: 7544129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vascular nitric oxide in physiological and pathological conditions.
    Marín J; Rodríguez-Martínez MA
    Pharmacol Ther; 1997 Aug; 75(2):111-34. PubMed ID: 9428001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction: clinical implications.
    Drexler H
    Prog Cardiovasc Dis; 1997; 39(4):287-324. PubMed ID: 9050817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived nitric oxide limits sympathetic neurogenic constriction in intestinal microcirculation.
    Nase GP; Boegehold MA
    Am J Physiol; 1997 Jul; 273(1 Pt 2):H426-33. PubMed ID: 9249518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bench to bedside: nitric oxide in emergency medicine.
    Lopez BL; Christopher TA; Griswold SK; Ma XL
    Acad Emerg Med; 2000 Mar; 7(3):285-93. PubMed ID: 10730840
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
    Goumas G; Tentolouris C; Tousoulis D; Stefanadis C; Toutouzas P
    Atherosclerosis; 2001 Feb; 154(2):255-67. PubMed ID: 11166757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries.
    Aldasoro M; Martínez C; Vila JM; Medina P; Lluch S
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):623-8. PubMed ID: 8964801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells.
    Walker DH; Popov VL; Crocquet-Valdes PA; Welsh CJ; Feng HM
    Lab Invest; 1997 Jan; 76(1):129-38. PubMed ID: 9010456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.
    Overend J; Martin W
    Br J Pharmacol; 2007 Feb; 150(4):488-93. PubMed ID: 17211453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of endothelium-derived relaxing factor (EDRF).
    Bassenge E
    Br J Clin Pharmacol; 1992; 34 Suppl 1(Suppl 1):37S-42S. PubMed ID: 1633078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of nitric oxide production in vascular endothelium and the significance as therapeutic target--special reference to the relationship with superoxides].
    Oike M
    Fukuoka Igaku Zasshi; 2000 Oct; 91(10):256-65. PubMed ID: 11215249
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide is the endothelium-derived relaxing factor in bovine pial arterioles.
    Fischer-Nakielski H; Schrör K
    Stroke; 1990 Dec; 21(12 Suppl):IV46-8. PubMed ID: 2124388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FMD vs. pharmacological approaches for endothelial function.
    Tanaka H
    J Appl Physiol (1985); 2005 Oct; 99(4):1627. PubMed ID: 16160030
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide, cardiovascular disease and physical exercise.
    Zago AS; Zanesco A
    Arq Bras Cardiol; 2006 Dec; 87(6):e264-70. PubMed ID: 17262101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.